Dermatitis clinical trials

Explore recruiting dermatitis clinical trials.

Recruiting dermatitis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dermatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Optimization of Cyclosporin therapy in atopic dermatitis through multiomic predictive models of treatment response (DermAtOmics)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Optimization of atopic dermatitis treatment that requires second-line systemic therapy through multiomic predictive models of treatment response (DermAtOmics-II)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Parallel-arm, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Atopic Dermatitis (COMPASS 2-AD)

Poland, Bulgaria, Germany, Czechia, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

Netherlands, Denmark, Hungary, Ireland, Portugal, Italy +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis

Netherlands, Spain, France, Italy, Germany, Bulgaria +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dermatitis trials by city

Dermatitis in Toronto Dermatitis in Vancouver Dermatitis in Montreal Dermatitis in Calgary Dermatitis in Edmonton Dermatitis in Ottawa Dermatitis in Winnipeg Dermatitis in Quebec City Dermatitis in Hamilton Dermatitis in Kitchener Dermatitis in London Dermatitis in Halifax Dermatitis in New York Dermatitis in Los Angeles Dermatitis in Chicago Dermatitis in Houston

Dermatitis clinical trials

Recruiting dermatitis studies right now

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

Effects of Treatments on Atopic Dermatitis

Also recruiting in Europe

Optimization of Cyclosporin therapy in atopic dermatitis through multiomic predictive models of treatment response (DermAtOmics)

Optimization of atopic dermatitis treatment that requires second-line systemic therapy through multiomic predictive models of treatment response (DermAtOmics-II)

A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

A Phase 2, Parallel-arm, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Atopic Dermatitis (COMPASS 2-AD)

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis

Dermatitis trials by city

Other conditions